A retrospective analysis of neuroendocrine tumour of pancreas: a single institute study


  • Yogen P. Chheda Department of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat
  • Deeksha Arora Department of General Surgery, Sri Krishna Hospital, Karamsad, Anand, Gujarat
  • Rutul Patel Department of Surgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, Gujarat




Pancreatic neuroendocrine tumour, Distal pancreatectomy, Pancreatico-duodenectomy


Background: The aim of the work was the clinical characteristics and analysis of preliminary results for surgical treatment of pancreatic neuroendocrine tumors (PNETs). This article deals with the classification of the Pancreatic Neuroendocrine Tumors (PNETs) and discusses their presentation, behaviour, treatment and prognosis.

Methods: This was a retrospective study of 70 patients of PNET done over a period of 3 years in The Gujarat Cancer and Research Institute, Ahmedabad. 24 patients who underwent surgical treatment for PNET were further evaluated for surgical outcome, 5yr disease free survival and overall survival.

Results: In this study of 70 patients, 61(87.14%) were non-functional. Approximately 77% of PNETs were advanced on presentation (57% metastatic and 20% locally advanced). 20 patients had disease resectable on presentation (11 NF + 9 F). These 20 patients belong to stage I and II of TNM staging system. Only 4 out of 40 metastatic diseases had locally resectable tumor. Of 24 patients who underwent surgery, 12 underwent pancreatico-duodenectomy, 6 underwent enucleation and 6 underwent distal pancreatectomy.

Conclusions: PNETs are uncommon tumor of pancreatic origin with presentation more commonly in males than females, usually in the 5th decade. Approximately 77% of patients are advanced or metastatic at presentation. Among those resectable, the Overall Survival for FPNETs and NFPNETs was 90% and 94% respectively and 5yr Disease Free Survival for the same was 100% and 84% respectively.



Klöppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2011;18(Suppl 1):S1-16.

Klöppel G, Rindi G, Perren A, Komminoth P, Klimstra DS. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: A statement. Virchows Arch. 2010;456(6):595-7.

Estrozi B, Bacchi CE. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clin. 2011;66(10):1671-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22012036.

Lloyd RV. Practical markers used in the diagnosis of neuroendocrine tumors. Endocr Pathol. 2003;14(4):293-301.

Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117-22.

Godwin JD. Carcinoid Tumors. An analysis of 2837 cases. Cancer. 1975;36(2):560-9.

Edge S, Byrd DR., Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. Springer. Available from: http://www.springer.com/us/book/9780387884400

Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. Karger Publishers. 2004;80(Suppl 1):3-7.

Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 2007;451 Suppl l:S9-27.


Hormone-Related Malignant Tumors. Springer Science & Business Media. 2012:269. https://books.google.com/books?id=lr7dBgAAQBAJ&pgis=1.

Radiology of the Pancreas. Springer Science & Business Media. 2012:355. https://books.google.com/books?id=3P5ICAAAQBAJ&pgis=1.

Forensic Pathology Reviews. Springer Science & Business Media; 2011;344 p. Available from: https://books.google.com/books?id=3ZOT2M8pLQC&pgis=1.

Kapran Y, Bauersfeld J, Anlauf M, Sipos B, Klöppel G. Multihormonality and entrapment of islets in pancreatic endocrine tumors. Virchows Arch. 2006;448(4):394–8.


Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711-9.

Anlauf M, Garbrecht N, Henopp T, Schmitt A, Schlenger R, Raffel A, et al. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol. 2006;12(34):5440-6.

Karger Medical and Scientific Publishers. Neuroendocrinology. 2006:66. Available from: https://books.google.com/books?id=ZJqZT4ZTkSUC&pgis=1.

Edis AJ, Grant CS, Egdahl RH. Manual of Endocrine Surgery. Springer Science & Business Media. 2012:325. Available from: https://books.google.com/books?id=LpDIAwAAQBAJ&pgis=1.

Pathology D of PWHCEELD of A. Pathology of the Pancreas, Gallbladder, Extrahepatic Biliary Tract, and Ampullary Region. Oxford University Press, USA. 2003;608. https://books.google.com/books?id=xIFWUWt617AC&pgis=1.




How to Cite

Chheda, Y. P., Arora, D., & Patel, R. (2017). A retrospective analysis of neuroendocrine tumour of pancreas: a single institute study. International Journal of Research in Medical Sciences, 3(11), 3041–3045. https://doi.org/10.18203/2320-6012.ijrms20150928



Original Research Articles